Connection
Terry Fry to Feasibility Studies
This is a "connection" page, showing publications Terry Fry has written about Feasibility Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.024 |
|
|
|
-
Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, Fry TJ, Orentas R, Sabatino M, Shah NN, Steinberg SM, Stroncek D, Tschernia N, Yuan C, Zhang H, Zhang L, Rosenberg SA, Wayne AS, Mackall CL. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015 Feb 07; 385(9967):517-528.
Score: 0.024